Melanoma
Top doctor defies cancer prognosis with world-first treatment
Professor Richard Scolyer is a world recognised leader in melanoma research, named co-Australian of the Year this year, with his friend and medical oncologist Dr Georgina Long. In May last year, while… Audio
AI screens patients for melanoma
An artificial intelligence programme has been created by MoleMap to be used by GPs, nurses and technicians to screen patients for melanoma, with an accuracy rate of over 90 percent, almost as accurate… Audio
Meet the winners of the 2021 Prime Minister's Science Prize
It's Prime Minister's Science Prize time! We meet some of the people awarded the 2021 prizes for their mahi. Audio
Greg Murphy urging Kiwi men to get regular health checks
Men's Health Week ambassador Greg Murphy is calling on New Zealand men to take care of their health and "find the time" to get regular medical check-ups, as a part of the build-up to this year's… Audio
Skin cancer screening at home
An innovation in cancer screening is helping detect melanomas at home. The Kiwi-designed MoleMap contactless triage tool can help people in remote areas or who simply can't get to a clinic. It was… Audio
Kiwi at the helm of melanoma treatment breakthrough in in Covid-ravaged Peru
Covid-19 has been brutal in Peru, with the country having the highest death rate per population in the world. But it's not all doom and gloom. Patrick Emanuel is part of a team who have invented a new… Audio
Is cost stopping people from getting dangerous moles removed?
Is the expense of getting moles removed putting people's health at risk? Audio
What skin cancers affect Kiwis?
Skin cancer expert Dr Sharad Paul talks to Jesse about the most common types of cancer affecting New Zealanders. Audio
Melanoma rates declining by 1% a year
New Zealand's melanoma rates very rarely give cause for celebration but there's been some good news today. Despite New Zealand having some of the highest rates of melanoma in the world, kiwis in their… Audio
Melanomas may be missed by doctors - study
Potentially lethal melanomas may be being missed by doctors because the formula they are taught to recognise skin cancers often fails to identify thick melanomas, a University of Otago researcher…
New melanoma self-test could save your life, say experts
A "highly accurate" online skin cancer test that can identify people at high risk of melanoma in 90 seconds has been developed by Australian researchers.
Calls for tougher sunscreen regulation
Calls are being made for mandatory & more regular testing of sunscreens, as Consumer NZ releases its full report into failing sun protection products. Unlike in Australia, sunscreens here are… Audio
New blood test to detect melanoma
A blood test that can help to diagnose melanoma in its early stages has been developed by researchers.
Detecting skin cancer through smart phone apps... Do they work?
A New Zealand-made mobile app has joined the fight against skin cancer to provide remote consultations with local skin specialists, and to encourage people to get suspicious skin lesions checked… Audio
Turning around NZ's alarming melanoma rates
New Zealand is unfortunately now recorded as having the highest melanoma rates in the world - overtaking Australia. Tony Reeder is associate professor and co-director of Cancer Society Social and… Audio
Pharmac and its role in making drugs available
Science communication student Garrett Chin talks with doctors and a health economist about the challenges that Pharmac faces in buying drugs, and what happens when new but expensvie drugs become… Audio
Healthy Skin
There'll be slipping, slopping and slapping on hats around the country at the moment, that's a safety slogan that's lasted over decades. But these days we know even this isn't it enough to protect us… Audio
Opdivo improves cancer patient's condition
The tumour of the first New Zealander to receive a publicly funded immunotherapy drug for melanoma has shrunk dramatically. Audio
NZ lagging in melanoma drug funding - study
New Zealand is still far behind Australia and the United Kingdom when it comes to funding of melanoma drugs, according to a new study.
Pharmac criticised for waiting too long to fund Keytruda
A woman who had Stage IV melanoma has criticised Pharmac for not funding Keytruda earlier, saying hundreds of lives could have been saved. Video
